Physician profile
Amber Young
NPI 1598419582
$4,371.25
in general payments reported to CMS, 2019-2025
19 companies · $369 in 2025
The $369 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $820 · 2023: $2,554 · 2024: $628 · 2025: $369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,450 · Travel and Lodging: $1,101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,449.65 |
| Travel and Lodging | $1,101.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,030.75 | 2022-2025 | Venaseal, Endurant Iis, In.Pact Admiral |
| Silk Road Medical, INC. | $851.00 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Inari Medical, INC. | $814.79 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Philips North America LLC | $158.18 | 2024 | (Dd1) Duo Hybrid, (Az7) Lasers, (6577) Visions 014 |
| Organogenesis INC. | $122.38 | 2023 | Puraply Antimicrobial |
| Novo Nordisk INC | $90.23 | 2023 | Ozempic |
| Leo Pharma INC. | $47.88 | 2025 | Anzupgo |
| Vertex Pharmaceuticals Incorporated | $43.00 | 2024-2025 | |
| Lemaitre Vascular, INC. | $26.23 | 2022 | |
| Fresenius USA Marketing, INC. | $23.85 | 2025 | Velphoro |
| Truvic Medical, INC. | $23.54 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $21.20 | 2025 | Exparel |
| Inspiremd Ltd | $20.61 | 2025 | Cguard Prime Carotid Stent System |
| Mozarc Medical US LLC | $19.51 | 2025 | Pta High Pressure Balloon Dilatation Catheter |
| W. L. Gore & Associates, INC. | $17.54 | 2024 | Excluder Conformable Aaa Endoprosthesis With Active Control |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $17.35 | 2024 | Biomonitor, Amvia Edge, Acticor 7 Vr-T Dx |
| Janssen Pharmaceuticals, INC | $15.54 | 2022 | |
| Bsn Medical INC | $14.13 | 2025 | |
| Boston Scientific Corporation | $13.54 | 2024 | Varithena Administration Pack |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.